CARDIAC TAMPONADE AS AN ADVERSE EFFECT OF ACALABRUTINIB IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA: CATCH THE CULPRIT

被引：0
|
作者：
Dang, Alexander [1 ]
Jancovich, Michael [1 ]
Soufi, Mohamad Khaled [1 ]
机构：
[1] Univ Texas Med Branch, Galveston, TX 77555 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2177 / 2177
页数：1
相关论文
共 50 条
  • [21] Acalabrutinib in treatment-naive chronic lymphocytic leukemia
    Byrd, John C.
    Woyach, Jennifer A.
    Furman, Richard R.
    Martin, Peter
    O'Brien, Susan
    Brown, Jennifer R.
    Stephens, Deborah M.
    Barrientos, Jacqueline C.
    Devereux, Stephen
    Hillmen, Peter
    Pagel, John M.
    Hamdy, Ahmed
    Izumi, Raquel
    Patel, Priti
    Wang, Min Hui
    Jain, Nitin
    Wierda, William G.
    BLOOD, 2021, 137 (24) : 3327 - 3338
  • [22] CNS Aspergillosis and Cryptococcosis with Cytomegalovirus Pneumonia in a Patient with Chronic Lymphocytic Leukemia Treated with Acalabrutinib
    Fallin, Taylor
    Thacker, Erica
    Sahra, Syeda
    Siegrist, Emily A.
    White, Bryan P.
    Summers, Katherine
    Shibib, Dena
    Sassine, Joseph
    JOURNAL OF PHARMACY PRACTICE, 2024, 37 (06) : 1391 - 1395
  • [23] Meta-analysis of the efficacy and adverse effects of acalabrutinib in the management of relapsed/refractory chronic lymphocytic leukemia
    Park, Daniel
    Chan-Golston, Alec M.
    Yan, Yueqi
    Al-Manaseer, Farris
    Akhtari, Mojtaba
    JOURNAL OF CHEMOTHERAPY, 2024,
  • [24] Meta-Analysis of the Efficacy and Adverse Effects of Acalabrutinib in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia
    Park, Daniel
    Chan-Golston, Alec M.
    Akhtari, Mojtaba
    BLOOD, 2023, 142
  • [25] Targeted Treatment of Chronic Lymphocytic Leukemia: Clinical Utility of Acalabrutinib
    Vitale, Candida
    Gibbons, Jamie Lynn
    Ferrajoli, Alessandra
    ONCOTARGETS AND THERAPY, 2021, 14 : 5507 - 5519
  • [26] Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
    Byrd, John C.
    Harrington, Bonnie
    O'Brien, Susan
    Jones, Jeffrey A.
    Schuh, Anna
    Devereux, Steve
    Chaves, Jorge
    Wierda, William G.
    Awan, Farrukh T.
    Brown, Jennifer R.
    Hillmen, Peter
    Stephens, Deborah M.
    Ghia, Paolo
    Barrientos, Jacqueline C.
    Pagel, John M.
    Woyach, Jennifer
    Johnson, Dave
    Huang, Jane
    Wang, Xiaolin
    Kaptein, Allard
    Lannutti, Brian J.
    Covey, Todd
    Fardis, Maria
    McGreivy, Jesse
    Hamdy, Ahmed
    Rothbaum, Wayne
    Izumi, Raquel
    Diacovo, Thomas G.
    Johnson, Amy J.
    Furman, Richard R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (04): : 323 - 332
  • [27] Fulminant cardiac tamponade in chronic lymphocytic leukaemia
    Giannini, O
    Schonenberger-Berzins, R
    ANNALS OF ONCOLOGY, 1997, 8 (11) : 1168 - 1169
  • [28] Severe adverse skin reaction to chlorambucil in a patient with chronic lymphocytic leukemia
    Aydogdu, I
    Ozcan, C
    Harputluoglu, M
    Karincaoglu, Y
    Turhan, O
    Ozcanu, A
    ANTI-CANCER DRUGS, 1997, 8 (05) : 468 - 469
  • [29] The Warburg Effect Confers Adverse Outcome in Chronic Lymphocytic Leukemia
    Gardner, Jeffrey R.
    Devlin, Sean M.
    Knapp, Kristina
    Bauli, Francesco
    Patel, Minal
    Lamanna, Nicole
    Frattini, Mark G.
    Brentjens, Renier
    Maslak, Peter
    Jurcic, Joseph G.
    Weiss, Mark A.
    Abdel-Wahab, Omar
    Scheinberg, David A.
    Heaney, Mark L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S131 - S131
  • [30] EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia
    Delgado, Julio
    Josephson, Filip
    Camarero, Jorge
    Garcia-Ochoa, Blanca
    Lopez-Anglada, Lucia
    Prieto-Fernandez, Carolina
    van Hennik, Paula B.
    Papadouli, Irene
    Gisselbrecht, Christian
    Enzmann, Harald
    Pignatti, Francesco
    ONCOLOGIST, 2021, 26 (03): : 242 - 249
12345